Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Intellia Therapeutics

Biotech & Life Sciences · Cambridge, United States · Founded 2014 · IPO 2016 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$1.12B
Market cap · Apr/2026
Revenue
$68M
Latest reported FY

Investors

8 investors on Intellia Therapeutics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 4 investors entered at this stage
Caribou Biosciences
Atlas Venture
Amblyotech
Novartis
Series B+ 4 investors entered at this stage
OrbiMed
University of California
Berkeley
Foresite Capital

Global footprint

Where Intellia Therapeutics has talent and traffic

AI talent share
0.7% of workforce is AI talent
(3 of 452 staff)
Core AI10.22%
Other AI20.44%
Non-AI workforce44999.34%
Web traffic by country
70K monthly visits
across markets
🇺🇸 United States40.9%
🇪🇸 Spain34.4%
🇮🇳 India8.7%
🇬🇧 United Kingdom3.6%
🇨🇦 Canada3.1%
Top 5 markets shown

Patent intelligence

$60M patent portfolio · 81 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value
$60M
5.4% of market cap · 33.6× smaller than top peer Ablynx ($2B)
81 active patent families
Where Intellia Therapeutics innovates Molecular biologyGenome editingBioinformaticsCell biologyCell
Tracks the peer median across all five Patsnap quality dimensions.

Quality vs same-sector peers

Intellia Therapeutics on the five Patsnap quality dimensions

Intellia Therapeutics in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Intellia Therapeutics concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Intellia Therapeutics and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Intellia Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo